ASSESSMENT OF COMPOSITE ENDPOINTS COMPRISING SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC, AND MOLECULAR IMPROVEMENT IN A PHASE 1B STUDY OF GB004, A GUT-TARGETED, HYPOXIA-INDUCIBLE FACTOR (HIF)-1? STABILIZER, IN MILD-TO-MODERATE ULCERATIVE COLITIS

Kartik Raghupathi  1     Robin Osterhout  1     Brian G. Feagan  2     William Sandborn  3     Courtney Van Biene  1     Allan Olson  1     Richard Aranda  1     Barrett G. Levesque  1     Silvio Danese  4    
1 Gossamer Bio, Inc., San Diego, United States
2 Alimentiv, Inc., London, Canada
3 University of California San Diego, San Diego, United States
4 Humanitas Research and Teaching Hospital, Milan, Italy

Topic
IBD, Immunology

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing